Business Description
Hemogenyx Pharmaceuticals PLC
ISIN : GB00BYX3WZ24
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.95 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.89 | |||||
Debt-to-EBITDA | -0.53 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 9.1 | |||||
3-Year EPS without NRI Growth Rate | -7.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.16 | |||||
9-Day RSI | 45.3 | |||||
14-Day RSI | 45.12 | |||||
6-1 Month Momentum % | -12.82 | |||||
12-1 Month Momentum % | -10.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.07 | |||||
Quick Ratio | 4.07 | |||||
Cash Ratio | 3.97 | |||||
Days Payable | 55.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -39.5 | |||||
Shareholder Yield % | -32.76 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -155.3 | |||||
ROA % | -97.11 | |||||
ROIC % | -240.11 | |||||
ROC (Joel Greenblatt) % | -258.47 | |||||
ROCE % | -106.88 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 5.5 | |||||
EV-to-EBIT | -3.23 | |||||
EV-to-EBITDA | -3.69 | |||||
EV-to-FCF | -3.85 | |||||
Earnings Yield (Greenblatt) % | -30.93 | |||||
FCF Yield % | -27.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Hemogenyx Pharmaceuticals PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.009 | ||
Beta | 0.05 | ||
Volatility % | 82.92 | ||
14-Day RSI | 45.12 | ||
14-Day ATR (€) | 0.001703 | ||
20-Day SMA (€) | 0.016 | ||
12-1 Month Momentum % | -10.53 | ||
52-Week Range (€) | 0.0105 - 0.06 | ||
Shares Outstanding (Mil) | 1,341.82 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Hemogenyx Pharmaceuticals PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Hemogenyx Pharmaceuticals PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Hemogenyx Pharmaceuticals PLC Frequently Asked Questions
What is Hemogenyx Pharmaceuticals PLC(STU:5HU)'s stock price today?
When is next earnings date of Hemogenyx Pharmaceuticals PLC(STU:5HU)?
Does Hemogenyx Pharmaceuticals PLC(STU:5HU) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |